...Schoenberg moving to Amazon to lead Health Services; Neil Lindsay to depart Last Week’s Headlines Weekend Must Reads on AI: its societal and economic effects, and why its developers see it as replacing God Short takes: Garner Health’s $100M Series E; Veradigm files financial reports for ’23/’24, moved to net loss; Rovex debuts autonomous in-hospital transport robot Post-holiday news roundup: Oracle Health acute care EHR market share crumbles to 20%–what that means; retail real estate downsizer marketing Walgreens leases; Oura files for US IPO, Swoop buys NimbleRx Holiday weekend roundup: VA asks for ‘cyberspeed’ 25% EHR budget bump, update on... Continue Reading
Search Results for veradigm
TTA’s May closing: Oracle’s acute care EHR share now 20% , Oura tests IPO, Veradigm catches up, Garner’s $100M raise, and the societal effects of the AI ‘religion’
28 May 2026 It’s a lighter news week, but our Must Reads are a little on the ‘heavy’ side. Oracle Health stays in the news with its eroding EHR market share down to 20% and what that means for their future. The Oura ring is testing the IPO market with a preliminary filing. And in more good news, Veradigm is finally catching up with filing its annual reports through 2024 and Garner Health garners $100 million. Our Must Reads are both on the subject of AI’s social and economic effects, coming from two vastly different perspectives. An article of... Continue Reading
Short takes: Garner Health’s $100M Series E; Veradigm files financial reports for ’23/’24, moved to net loss; Rovex debuts autonomous in-hospital transport robot
...Research Agent) are targeted to employers and benefit managers as a service to connect employees with high-performing in-network physicians, based on clinical performance data and claims information, and to save on total healthcare spend. The company claims that they serve over 700 companies. The app is still available to individuals as a free download. Release Veradigm finally files its financial reports for 2023 and 2024, and they’re not cheering. This took the form of a ‘Super 10-K’, a comprehensive annual report that covers two fiscal years, as promised on Veradigm’s investor call last February. 2023 to 2024 results weren’t cheering... Continue Reading
Short newsy takes: Amazon Connect Health AI, UHS buys Talkspace for $835M, Oura buys Doublepoint, Science Corp.’s $230M raise, VSee’s debuts first autonomous telehealth robot
...contact center platform. Netsmart, Veradigm, and Greenway Health all use it, with Netsmart claiming an increase in ambient documentation adoption by 275% in its 1,300+ client network. Amazon release, HIStalk 3/6/26, Mobihealthnews UHS beefs up its behavioral health capabilities with Talkspace. Universal Health Services (UHS) is a national for-profit provider of health services that include acute care hospitals, behavioral health, healthcare management, and even a health plan. For UHS, expanding their behavioral health services faced staffing shortages that has stymied patient utilization and growth, plus creates a continuum of in-person and virtual telemental health. Talkspace was a fairly early entrant... Continue Reading
Veradigm won’t face SEC enforcement action, cuts 15% of staff, forecasts further retrenching for 2026 growth
...This was topped by an SEC enforcement investigation and a July data breach. It was not until last March that Veradigm provided a 2022 financial report…still unaudited. Some good news arrived last week. The Securities and Exchange Commission (SEC) informed Veradigm that the investigation, pending since January 2024, has been concluded. The SEC does not intend to recommend an enforcement action based on the available information. Former CEO Richard Poulton and former CFO Leah Jones, both of whom resigned in December 2023, received similar letters, according to the filing. Veradigm SEC Form 8-K. Healthcare Dive The current CEO, Donald Trigg,... Continue Reading
Editor Donna is back. Here’s the catchup.
...of other acquisitions and sales rounded up in HISTalk 1 October, indicating a certain liveliness in the market: specialty care coordinator Switchboard acquiring Conduce Health (undisclosed amount), Sunstone Partners taking a majority stake in healthcare cybersecurity/compliance firm Clearwater, AI voice agent developer Assist Health tagging a $76 million Series B round, and others. In amazement…. Veradigm still can’t get itself current with its financial filings and submit itself for Nasdaq relisting as of this week. Revenue is still flat, they repurchased $180 million in convertible notes, and got itself a new CEO, Donald Trigg, in what has been a revolving... Continue Reading
Short takes: Veradigm’s interim CEO departing, Blue Shield CA breached 4.8M members’ PHI to Google, advice on expanded M&A premarket notification rules
Veradigm’s interim CEO departing, CFO continuing. Tom Langan, who has been in place as Veradigm’s CEO for the last 11 months, will be departing after a little more than 13 months, according to Veradigm’s SEC Form 8-K securities filing dated 22 April. The former president and chief commercial officer (CCO), who replaced an earlier interim CEO, Dr. Dr. Shih-Yin (“Yin”) Ho, on 7 June 2024, has signed a separation agreement effective 31 July. According to the filing, the Veradigm board will be resuming a search for a permanent CEO. Mr. Langan declined the opportunity to participate as a candidate. Lee... Continue Reading
Rock Health’s digital health Q1: more money, fewer deals, more additions and partnerships in ‘leapfrogging’
...tech as the market changes or better tech emerges. Channel Partnerships. Companies, by adding partners, add capability at low cost and reach, though the logistics of partnering, the integration cost and quality of service aren’t easy lifts. Engaging Disruptors. Companies invested in certain standard processes can expand by allying with their disruptors, versus viewing them as competitors. What’s not mentioned in the report are the high profile failures this quarter: 23andMe’s bankruptcy, Walgreens’ sale to Sycamore Partners, and Veradigm’s failure to sell itself. Given the past few months, we’ll be doing a lot of ’embracing uncertainty’ this year! Also FierceHealthcare... Continue Reading
Short takes: interesting takeaways from the Veradigm earnings call, VA cuts ~6 EHRM contracts; mergers for DispatchHealth-Medically Home, Wysa-April Health
...The accumulation of things that just aren’t tucked, tied, and moving forward gives the impression of uncertainty. And uncertainty is a bad place to be in a billion-dollar business. Veradigm consists of a complex mix of businesses. Yet the CEO, Tom Langan, is still ‘interim’ after 10 months which affects the leadership. Months ago, the company was for sale, yet all the interested bidders who could have well afforded Veradigm took a pass. Now they are facing a ‘standalone future’. Right after that announcement, an activist investor intervened and is now calling the shots on board members [TTA 19 Mar,... Continue Reading
News roundup: NHS England to be abolished, absorbed into UK DHSC, while IT glitch shorts 5,200 from screenings; Veradigm *finally* files 2022 financials (updated), VA-Oracle EHR now promises 13 installs in 2026
...respective years ($0.77), $1.01, and $4.37. Now for 2023 and 2024…. Veradigm release is a long read Updated: Healthcare Dive confirmed Veradigm’s flat revenue projection for 2025. Two new board directors and a chairman were appointed: Jonathan Sacks, a partner at Stonehill Capital Management, and Bruce Felt, CFO at cloud software company Domo on the board, and Lou Silverman as chairman. Mr. Silverman joined the board last month and replaces Greg Garrison, who last month announced his retirement after the 2022 financials were filed. Under the agreement with investor Kent Lake PR LLC, all had to be approved by them... Continue Reading
Most Recent Comments